479 related articles for article (PubMed ID: 20578137)
1. Newborn and carrier screening for spinal muscular atrophy.
Prior TW; Snyder PJ; Rink BD; Pearl DK; Pyatt RE; Mihal DC; Conlan T; Schmalz B; Montgomery L; Ziegler K; Noonan C; Hashimoto S; Garner S
Am J Med Genet A; 2010 Jul; 152A(7):1608-16. PubMed ID: 20578137
[TBL] [Abstract][Full Text] [Related]
2. Spinal muscular atrophy: a time for screening.
Prior TW
Curr Opin Pediatr; 2010 Dec; 22(6):696-702. PubMed ID: 20829691
[TBL] [Abstract][Full Text] [Related]
3. Spinal muscular atrophy: newborn and carrier screening.
Prior TW
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255
[TBL] [Abstract][Full Text] [Related]
4. Improving detection and genetic counseling in carriers of spinal muscular atrophy with two copies of the SMN1 gene.
Alías L; Barceló MJ; Bernal S; Martínez-Hernández R; Also-Rallo E; Vázquez C; Santana A; Millán JM; Baiget M; Tizzano EF
Clin Genet; 2014 May; 85(5):470-5. PubMed ID: 23799925
[TBL] [Abstract][Full Text] [Related]
5. Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.
Botta A; Tacconelli A; Bagni I; Giardina E; Bonifazi E; Pietropolli A; Clementi M; Novelli G
Neurology; 2005 Nov; 65(10):1631-5. PubMed ID: 16301493
[TBL] [Abstract][Full Text] [Related]
6. Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
Su YN; Hung CC; Lin SY; Chen FY; Chern JP; Tsai C; Chang TS; Yang CC; Li H; Ho HN; Lee CN
PLoS One; 2011 Feb; 6(2):e17067. PubMed ID: 21364876
[TBL] [Abstract][Full Text] [Related]
7. Perspectives in genetic counseling for spinal muscular atrophy in the new therapeutic era: early pre-symptomatic intervention and test in minors.
Serra-Juhe C; Tizzano EF
Eur J Hum Genet; 2019 Dec; 27(12):1774-1782. PubMed ID: 31053787
[TBL] [Abstract][Full Text] [Related]
8. [Quantitative analysis of the genes determining spinal muscular atrophy].
Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
[TBL] [Abstract][Full Text] [Related]
9. Spinal muscular atrophy.
D'Amico A; Mercuri E; Tiziano FD; Bertini E
Orphanet J Rare Dis; 2011 Nov; 6():71. PubMed ID: 22047105
[TBL] [Abstract][Full Text] [Related]
10. [Result of carrier screening for spinal muscular atrophy among 3049 reproductive-age individuals from Yunnan region].
Zhang Y; Wang L; He J; Guo J; Jin C; Tang X; Zhang J; Chen H; Zhang J; Su J; Zhu B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Apr; 37(4):384-388. PubMed ID: 32219818
[TBL] [Abstract][Full Text] [Related]
11. Spinal Muscular Atrophy: Overview of Molecular Diagnostic Approaches.
Prior TW; Nagan N
Curr Protoc Hum Genet; 2016 Jan; 88():9.27.1-9.27.13. PubMed ID: 26724723
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and characterization of a high-resolution melting analysis kit for rapid carrier-screening test of spinal muscular atrophy.
Wang KC; Chang CC; Chang YF; Wang SH; Chiang CK; Tsai CP
J Neurogenet; 2015; 29(2-3):113-6. PubMed ID: 25895942
[TBL] [Abstract][Full Text] [Related]
13. Preconception or prenatal acceptance of SMN1 gene carrier screening and carrier rate of spinal muscular atrophy: a retrospective study in 18,818 reproductive age women in Wuhan area of China.
Sun Y; Ma S; Xiao J; Wu J; Wu Y; Shi X; Li S; Feng L; Chen S
J Assist Reprod Genet; 2024 Jan; 41(1):127-133. PubMed ID: 37991656
[TBL] [Abstract][Full Text] [Related]
14. Intelligent Ratio: A New Method for Carrier and Newborn Screening in Spinal Muscular Atrophy.
Cavdarli B; Ozturk FN; Guntekin Ergun S; Ergun MA; Dogan O; Percin EF
Genet Test Mol Biomarkers; 2020 Sep; 24(9):569-577. PubMed ID: 32721240
[No Abstract] [Full Text] [Related]
15. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
[TBL] [Abstract][Full Text] [Related]
16. Carrier frequency of SMA by quantitative analysis of the SMN1 deletion in the Iranian population.
Hasanzad M; Azad M; Kahrizi K; Saffar BS; Nafisi S; Keyhanidoust Z; Azimian M; Refah AA; Also E; Urtizberea JA; Tizzano EF; Najmabadi H
Eur J Neurol; 2010 Jan; 17(1):160-2. PubMed ID: 19538222
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.
Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B
Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Testing for Patients with Spinal Muscular Atrophy.
Brandsema JF; Gross BN; Matesanz SE
Clin Lab Med; 2020 Sep; 40(3):357-367. PubMed ID: 32718505
[TBL] [Abstract][Full Text] [Related]
19. [Carrier screening for spinal muscular atrophy in 4719 pregnant women in Shanghai region].
Gong B; Zhang L; Hou YP; Hu HY; Li HC; Tan MY; Chen J; Yu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):670-2. PubMed ID: 24327144
[TBL] [Abstract][Full Text] [Related]
20. Carrier frequency of spinal muscular atrophy in Thailand.
Dejsuphong D; Taweewongsounton A; Khemthong P; Chitphuk S; Stitchantrakul W; Sritara P; Tunteeratum A; Sura T
Neurol Sci; 2019 Aug; 40(8):1729-1732. PubMed ID: 31004230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
